DUPILUMAB for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 5,681 adverse event reports in the FDA FAERS database where DUPILUMAB was used for Psoriasis.
Most Reported Side Effects for DUPILUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pruritus | 44,279 | 11.7% | 53 | 1,105 |
| Dermatitis atopic | 33,670 | 8.9% | 27 | 570 |
| Product use in unapproved indication | 33,452 | 8.8% | 317 | 1,795 |
| Rash | 30,895 | 8.2% | 37 | 874 |
| Injection site pain | 27,799 | 7.3% | 15 | 542 |
| Drug ineffective | 23,712 | 6.3% | 38 | 745 |
| Dry skin | 20,239 | 5.3% | 19 | 371 |
| Eczema | 20,020 | 5.3% | 18 | 469 |
| Product dose omission issue | 18,189 | 4.8% | 21 | 598 |
| Condition aggravated | 16,459 | 4.3% | 34 | 652 |
| Arthralgia | 15,176 | 4.0% | 18 | 577 |
| Inappropriate schedule of product administration | 14,927 | 3.9% | 30 | 509 |
| Asthma | 12,312 | 3.3% | 24 | 1,689 |
| Skin exfoliation | 11,738 | 3.1% | 13 | 323 |
| Dry eye | 10,892 | 2.9% | 6 | 209 |
Other Indications for DUPILUMAB
Dermatitis atopic (179,563)
Asthma (57,014)
Eczema (28,882)
Nasal polyps (21,908)
Eosinophilic oesophagitis (13,948)
Dermatitis (9,959)
Neurodermatitis (9,956)
Dermatitis allergic (8,136)
Product used for unknown indication (5,301)
Illness (4,122)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)